CY1124062T1 - Στειρα χρωματογραφια και διαδικασιες παρασκευης - Google Patents

Στειρα χρωματογραφια και διαδικασιες παρασκευης

Info

Publication number
CY1124062T1
CY1124062T1 CY20211100048T CY211100048T CY1124062T1 CY 1124062 T1 CY1124062 T1 CY 1124062T1 CY 20211100048 T CY20211100048 T CY 20211100048T CY 211100048 T CY211100048 T CY 211100048T CY 1124062 T1 CY1124062 T1 CY 1124062T1
Authority
CY
Cyprus
Prior art keywords
chromatography
column
cycle
irradiated
resin
Prior art date
Application number
CY20211100048T
Other languages
Greek (el)
English (en)
Inventor
Rahul GODAWAT
Veena WARIKOO
Rohan PATIL
Konstantin Konstantinov
Venkat Kishore RYAKALA
Mahsa ROHANI
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of CY1124062T1 publication Critical patent/CY1124062T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/081Gamma radiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1807Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using counter-currents, e.g. fluidised beds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022Alpha-galactosidase (3.2.1.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
CY20211100048T 2014-01-17 2021-01-21 Στειρα χρωματογραφια και διαδικασιες παρασκευης CY1124062T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461928906P 2014-01-17 2014-01-17
PCT/US2015/011698 WO2015109146A1 (en) 2014-01-17 2015-01-16 Sterile chromatography and manufacturing processes

Publications (1)

Publication Number Publication Date
CY1124062T1 true CY1124062T1 (el) 2022-05-27

Family

ID=52630479

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100048T CY1124062T1 (el) 2014-01-17 2021-01-21 Στειρα χρωματογραφια και διαδικασιες παρασκευης

Country Status (19)

Country Link
US (4) US10087214B2 (enExample)
EP (1) EP3094640B1 (enExample)
JP (2) JP6691047B2 (enExample)
KR (1) KR102326354B1 (enExample)
CN (1) CN106103464B (enExample)
AU (1) AU2015206422B2 (enExample)
BR (1) BR112016016329B1 (enExample)
CA (1) CA2936951C (enExample)
CY (1) CY1124062T1 (enExample)
DK (1) DK3094640T3 (enExample)
ES (1) ES2841141T3 (enExample)
HK (1) HK1227042B (enExample)
HU (1) HUE052611T2 (enExample)
IL (1) IL246774B (enExample)
MX (1) MX376882B (enExample)
RU (1) RU2679133C2 (enExample)
SG (1) SG11201605626SA (enExample)
TW (2) TWI671312B (enExample)
WO (1) WO2015109146A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1219751A1 (zh) 2013-02-22 2017-04-13 Genzyme Corporation 微载体灌注培养方法及其用途
CN105143443A (zh) 2013-02-22 2015-12-09 建新公司 微载体灌注培养方法及其用途
SG10201709131UA (en) 2013-03-08 2017-12-28 Genzyme Corp Continuous purification of therapeutic proteins
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法(seed train processes)及其用途
WO2016106192A2 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell
DE102015005244A1 (de) * 2015-04-24 2016-11-10 Sartorius Stedim Biotech Gmbh Verfahren zur Sterilisierung eines Chromatographiematerials und danach sterilisiertes Chromatographiematerial
SG11202003793WA (en) 2017-10-30 2020-05-28 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN112292601B (zh) * 2018-05-24 2024-07-02 西格马-奥尔德里奇有限责任公司 蛋白定量分析
JP7699537B2 (ja) 2018-08-31 2025-06-27 ジェンザイム・コーポレーション 無菌クロマトグラフィー樹脂および製造方法におけるその使用
EP3947705A1 (en) * 2019-04-03 2022-02-09 Genzyme Corporation Continuous production of recombinant proteins
IL292410A (en) 2019-10-22 2022-06-01 Genzyme Corp Sequential product monitoring for integrated continuous biomanufacturing
CN115475258A (zh) * 2022-09-06 2022-12-16 江苏丰华生物制药有限公司 一种注射用替奈普酶纯化工艺

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401108A (en) 1980-02-13 1983-08-30 Thomas Jefferson University Radioactive material loading, calibration and injection systems
SU1033181A1 (ru) 1982-02-02 1983-08-07 Томское Отделение Охтинского Ордена Ленина И Ордена Трудового Красного Знамени Научно-Производственного Объединения "Пластполимер" Способ обработки полимерного сорбента дл хроматографии
JPS6075530A (ja) 1983-09-30 1985-04-27 Asahi Chem Ind Co Ltd 金属元素の新しい分離精製方法
US4559175A (en) 1984-04-19 1985-12-17 The United States Of America As Represented By The Secretary Of The Air Force Halo-substituted diphospha-s-triazines and their derivatives
US4885250A (en) 1987-03-02 1989-12-05 E. I. Du Pont De Nemours And Company Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports
US5612016A (en) 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
AU6355790A (en) 1989-08-04 1991-03-11 Peter Grandics An integrated cell culture-protein purification system for the automated production and purification of cell culture products
US5244816A (en) 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
WO1992017403A1 (en) 1991-04-05 1992-10-15 Brigham Young University Support bonded polyalkylene-polyamine-poly(carboxylic acid) and extraction of metal ions therewith
RU2034853C1 (ru) 1992-07-14 1995-05-10 Научно-исследовательский институт строительных материалов при Томской государственной инженерно-строительной академии Способ получения полимерного сорбента для хроматографии
JP2871435B2 (ja) 1993-04-22 1999-03-17 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 親水性ポリマー被覆パーフルオロカーボンポリマーベースのマトリックスの製造方法
JPH07110229A (ja) 1993-10-12 1995-04-25 Nkk Corp 金属ストリップループの最下点位置検出装置
US5478924A (en) 1994-02-16 1995-12-26 Cramer; Steven M. Displacement chromatography of proteins using low molecular weight displacers
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5423982A (en) 1994-05-31 1995-06-13 Biosepra Inc. Liquid chromatography column adapted for in situ chemical sterilization
US5610285A (en) 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US6359114B1 (en) 1995-06-07 2002-03-19 Aphton Corp. System for method for the modification and purification of proteins
US5691152A (en) 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
AR005035A1 (es) 1995-12-11 1999-04-07 Merck Patent Ges Mit Beschränkter Haftung Procedimiento para preparar proteinas recombinantes en e. coli, mediante fermentacion con gran concentracion de celulas.
SI0950067T1 (sl) 1996-11-27 2007-12-31 Genentech Inc Afinitetno čiščenje polipeptida na proteinskemA matriksu
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US6265542B1 (en) 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
SI1308455T1 (sl) 1998-05-06 2006-08-31 Genentech Inc Sestavek, ki obsega protitelesa anti-HER2
DE19858892A1 (de) 1998-12-19 2000-06-21 Merck Patent Gmbh Kontinuierliches Verfahren zur Trennung von Stoffen nach Molekülgröße
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
GB0028879D0 (en) 2000-11-27 2001-01-10 Prometic Biosciences Ltd Adsorbents and their use
SK10472003A3 (sk) 2001-02-23 2004-03-02 Immunex Corporation Zvýšený výťažok aktívnych proteínov
ITBO20010426A1 (it) 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US20030095890A1 (en) 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
AU2002343100A1 (en) * 2001-11-27 2003-06-10 Prometic Biosciences Ltd. The use of metal-chelating adsorbents
US6660172B2 (en) 2002-01-31 2003-12-09 Koslow Technologies Corporation Precoat filtration media and methods of making and using
AU2003210802B2 (en) 2002-02-05 2009-09-10 Genentech Inc. Protein purification
SI1501369T1 (sl) 2002-04-26 2015-10-30 Genentech, Inc. Neafinitetno čiščenje proteinov
US6902909B2 (en) 2002-07-09 2005-06-07 Synthecon, Inc. Methods for efficient production of mammalian recombinant proteins
SI1543038T2 (sl) 2002-09-11 2020-12-31 Genentech, Inc. Čiščenje proteinov
AU2003272368C1 (en) 2002-09-13 2009-07-23 Biogen Idec Inc. Method of purifying polypeptides by simulated moving bed chromatography
US7157276B2 (en) 2003-06-20 2007-01-02 Biogen Idec Inc. Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
AU2005216847B2 (en) 2004-02-27 2010-04-01 Cytiva Bioprocess R&D Ab A process for the purification of antibodies
PL1718675T3 (pl) 2004-02-27 2013-09-30 Octapharma Ag Sposób uzyskiwania oczyszczonego preparatu przeciwciał pozbawionego wirusów
MXPA06014099A (es) 2004-06-04 2007-05-09 Xcellerex Inc Sistemas biorreactores desechables y metodos.
US20060004621A1 (en) 2004-06-30 2006-01-05 Malek Kamal M Real-time selection of survey candidates
WO2006026248A1 (en) 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
HUE027136T2 (en) 2004-09-30 2016-08-29 Bayer Healthcare Llc Tools and procedures for the integrated, continuous production of biological molecules
US20060153861A1 (en) 2004-09-30 2006-07-13 Scheinberg David A BCR-ABL imatinib resistance-associated peptides and methods of use thereof
CA2582113C (en) 2004-10-21 2013-07-30 Ge Healthcare Bio-Sciences Ab A method of antibody purification
KR101370253B1 (ko) 2004-10-22 2014-03-05 암젠 인크 재조합 항체의 재접힘 방법
EP1836316A4 (en) 2004-12-22 2009-07-22 Ambrx Inc PROCESS FOR EXPRESSION AND CLEANING OF RECOMBINANT HUMAN GROWTH HORMONE
CN101137399B (zh) 2005-03-07 2012-08-29 通用电气健康护理生物科学股份公司 灭菌方法和系统、获得的无菌填充色谱柱及其用途
CN1923290A (zh) 2005-04-29 2007-03-07 成都夸常医学工业有限公司 一种病毒灭活方法、其中所用的处理系统以及装置
WO2007055789A2 (en) 2005-10-31 2007-05-18 Neose Technologies, Inc. Expression of soluble therapeutic proteins
AU2006329963B2 (en) 2005-12-06 2011-06-09 Amgen Inc. Polishing steps used in multi-step protein purification processes
US7673757B2 (en) 2006-02-17 2010-03-09 Millipore Corporation Adsorbent filter media for removal of biological contaminants in process liquids
US20080031877A1 (en) 2006-02-17 2008-02-07 Antonello Covacci Purification of bacterial antigens
US8117924B2 (en) 2006-04-21 2012-02-21 Bayer Healthcare Llc Apparatus, system, and method for in-situ measurements
US20080132688A1 (en) 2006-09-22 2008-06-05 Amgen Inc. Methods for Removing Viral Contaminants During Protein Purification
US20080207487A1 (en) 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CN101600345B (zh) 2007-02-01 2013-07-17 安万托特性材料股份有限公司 色谱介质和色谱设备储存溶液及其用途
US9597610B2 (en) 2007-03-09 2017-03-21 Ge Healthcare Bioprocess R&D Ab Packing system and method for chromatography columns
GB0704603D0 (en) 2007-03-09 2007-04-18 Ge Healthcare Bio Sciences Ab Packing system and method for chromatography columns
AU2007351639B2 (en) 2007-04-17 2012-12-13 Sartorius Stedim Chromatography Systems Ltd. Method and device for continuous membrane adsorption
JP5571552B2 (ja) 2007-06-15 2014-08-13 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー クロマトグラフィー法
US7809258B2 (en) 2007-07-06 2010-10-05 Flir Systems Ab Camera and method for use with camera
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
PT2215117E (pt) 2007-10-30 2015-04-01 Genentech Inc Purificação de anticorpo por cromatografia de troca de catiões
JP5230654B2 (ja) 2007-12-27 2013-07-10 大塚製薬株式会社 エクオール合成に関与する酵素
EP2300497B1 (en) * 2008-06-24 2012-08-08 Octapharma AG A process of purifying coagulation factor viii
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製
CN102271775A (zh) * 2008-12-08 2011-12-07 诺沃-诺迪斯克有限公司 多肽的逆流提纯
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
US8728479B2 (en) 2009-03-31 2014-05-20 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
US20120104380A1 (en) 2009-06-22 2012-05-03 Merck Patent Gmbh Conducting formulation
US8580554B2 (en) 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture
BR112012010249A2 (pt) 2009-10-29 2015-09-22 Ascendis Pharma As esterilização de hidrógeis biodegradáveis
CA2785198C (en) * 2009-12-22 2018-02-27 Ge Healthcare Bio-Sciences Ab Method for dry packing of chromatography columns
GB0922426D0 (en) 2009-12-22 2010-02-03 Ge Healthcare Bio Sciences Ab Containers for chromatography media
WO2011147762A2 (en) 2010-05-25 2011-12-01 Bayer Pharma Aktiengesellschaft Stabilized radiopharmaceutical composition
JP5932780B2 (ja) * 2010-06-03 2016-06-08 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーカラムモジュールの並列アセンブリ
WO2012049324A2 (en) 2010-10-15 2012-04-19 Straumann Holding Ag New emd formulation comprising pga
WO2012071135A2 (en) 2010-11-23 2012-05-31 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
WO2012073677A1 (ja) 2010-11-29 2012-06-07 三菱電機株式会社 レーザ加工機の光路構造
CN103221105B (zh) 2010-12-03 2015-11-25 通用电气健康护理生物科学股份公司 生物聚合物色谱的系统和工艺
WO2012078677A2 (en) 2010-12-06 2012-06-14 Tarpon Biosystems, Inc. Continuous processing methods for biological products
CN102321316B (zh) 2011-08-25 2013-04-24 上海恒方大高分子材料科技有限公司 一种适用于γ射线辐照消毒的医用PVC材料及其制备方法
IN2014DN01802A (enExample) 2011-09-30 2015-05-15 Bayer Ip Gmbh
EP2656892A1 (en) * 2012-04-23 2013-10-30 Merck Patent GmbH Chromatography method
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
JP6182210B2 (ja) 2012-06-29 2017-08-16 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質精製プロセス中のウイルスの不活性化方法
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
WO2014066471A1 (en) 2012-10-24 2014-05-01 Genzyme Corporation Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers
SG10201709131UA (en) 2013-03-08 2017-12-28 Genzyme Corp Continuous purification of therapeutic proteins
CN103223333B (zh) 2013-04-15 2015-01-14 河海大学 一种含双偕胺肟基的改性硅胶吸附剂及其制备方法
US20240100450A9 (en) 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
EP3094391B1 (en) 2014-01-17 2024-11-20 Repligen Corporation Sterilizing chromatography columns
TWI671312B (zh) * 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
US10925986B2 (en) 2017-01-30 2021-02-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for reducing bioburden in chromatography
JP7699537B2 (ja) 2018-08-31 2025-06-27 ジェンザイム・コーポレーション 無菌クロマトグラフィー樹脂および製造方法におけるその使用

Also Published As

Publication number Publication date
MX2016009295A (es) 2016-11-11
US20200369718A1 (en) 2020-11-26
DK3094640T3 (da) 2021-02-08
US20150203529A1 (en) 2015-07-23
ES2841141T3 (es) 2021-07-07
BR112016016329A8 (pt) 2020-06-16
JP2017506218A (ja) 2017-03-02
TW201936628A (zh) 2019-09-16
RU2679133C2 (ru) 2019-02-06
US20150203532A1 (en) 2015-07-23
KR20160107325A (ko) 2016-09-13
AU2015206422B2 (en) 2020-05-21
IL246774B (en) 2020-06-30
CN106103464A (zh) 2016-11-09
TW201612189A (en) 2016-04-01
EP3094640A1 (en) 2016-11-23
EP3094640B1 (en) 2020-11-18
RU2019102195A (ru) 2019-02-22
JP7055161B2 (ja) 2022-04-15
TWI671312B (zh) 2019-09-11
US20180354986A1 (en) 2018-12-13
RU2016133483A (ru) 2018-02-22
US11912739B2 (en) 2024-02-27
BR112016016329B1 (pt) 2023-12-26
HUE052611T2 (hu) 2021-05-28
TWI709570B (zh) 2020-11-11
HK1227042A1 (en) 2017-10-13
JP2020121995A (ja) 2020-08-13
CA2936951A1 (en) 2015-07-23
BR112016016329A2 (enExample) 2017-08-08
WO2015109146A1 (en) 2015-07-23
MX376882B (es) 2025-03-07
RU2016133483A3 (enExample) 2018-08-20
US10087214B2 (en) 2018-10-02
HK1227042B (en) 2021-07-16
AU2015206422A1 (en) 2016-08-18
CN106103464B (zh) 2023-01-03
SG11201605626SA (en) 2016-08-30
CA2936951C (en) 2023-03-28
JP6691047B2 (ja) 2020-04-28
IL246774A0 (en) 2016-08-31
KR102326354B1 (ko) 2021-11-12

Similar Documents

Publication Publication Date Title
CY1124062T1 (el) Στειρα χρωματογραφια και διαδικασιες παρασκευης
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
CY1126115T1 (el) Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων
CY1123441T1 (el) Μορια με ειδικοτητα στα cd45 και cd79
CY1121893T1 (el) Μορια αντισωματος κατα της τιμ-3 και χρησεις αυτων
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
CY1121542T1 (el) Μορια αντισωματων σε pd-1 και χρηση αυτων
IL274891A (en) Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
CR20170032A (es) Moleculas biespecíficas de unión a antígeno activadoras de células t
AR109771A1 (es) Moléculas biespecíficas de unión a antígeno activadoras de células t
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
AR106201A1 (es) Moléculas biespecíficas de unión a antígeno activadoras de células t
MX2018007451A (es) Inmunoglobulinas conjugadas con lisina c-terminal.
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
IL285923A (en) Compositions, methods, and kits for delivery of polyribonucleotides
EA202091989A1 (ru) Способы лечения язвенного колита
MX375524B (es) Anticuerpos anti-axl.
BR112017009764A2 (pt) anticorpos biespecíficos e métodos de uso em oftalmologia
CY1124727T1 (el) Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων
CY1124399T1 (el) Μεθοδοι για την αυξηση του βιαια εκπνεομενου ογκου σε ασθματικους με τη χρηση μπενραλιζουμαμπης
CY1125536T1 (el) Συνθεσεις για τη θεραπεια της αμυλοειδωσης
MX2020013746A (es) Metodos y composiciones para incrementar la produccion de arn bicatenario.
CL2019000957A1 (es) Método y aparato para representación compacta de datos bioinformáticos.
EP3401336A4 (en) ANTI-PCSK9 ANTIBODIES, ASSOCIATED ANTIGEN BINDING FRAGMENT, AND ASSOCIATED MEDICAL APPLICATION
EA201892085A1 (ru) Новые белки, полученные из альфа-1-микроглобулина, и их применение